Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.
Collaborations between industry and academia are steadily gaining importance. To combine expertises Bayer Healthcare has set up a novel open innovation approach called Grants4Targets. Ideas on novel drug targets can easily be submitted to http://www.grants4targets.com. After a review process, grants are provided to perform focused experiments to further validate the proposed targets. In addition to financial support specific know-how on target validation and drug discovery is provided. Experienced scientists are nominated as project partners and, depending on the project, tools or specific models are provided. Around 280 applications have been received and 41 projects granted. According to our experience, this type of bridging fund combined with joint efforts provides a valuable tool to foster drug discovery collaborations.
Global Drug Discovery Bayer Schering Pharma, Muellerstraße 178, 13342 Berlin, Germany. Monika.Lessl@bayer.com
Monika
M
Lessl
Stefanie
S
Schoepe
Anette
A
Sommer
Martin
M
Schneider
Khusru
K
Asadullah
D003299:Cooperative Behavior; D004059:Diffusion of Innovation; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry; D005381:Financing, Organized; D006801:Humans; D058990:Molecular Targeted Therapy; D004364:Pharmaceutical Preparations; D057170:Translational Research, Biomedical
D004364:Pharmaceutical Preparations